Gut Mx

Australia - English - Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:
polaprezinc,Saccharomyces cerevisiae (Boulardii)
Available from:
Bio Concepts Pty Ltd
Authorization status:
Listed
Authorization number:
321711

Public Summary

Summary for ARTG Entry:

321711

Gut Mx

ARTG entry for

Medicine Listed

Sponsor

Bio Concepts Pty Ltd

Postal Address

PO Box 190,Banyo,Brisbane, QLD, 4014

Australia

ARTG Start Date

13/08/2019

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Conditions

Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be

kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1. Gut Mx

Product Type

Single Medicine Product

Effective date

13/08/2019

Permitted Indications

Antioxidant/Reduce free radicals formed in the body

Helps reduce/decrease free radical damage to body cells

Maintain/support healthy eye function

Maintain/support healthy eyesight/vision

Maintain/support healthy growth and development

Maintain/support general health and wellbeing

Maintain/support healthy mucous linings of the digestive system

Maintain/support good/beneficial/friendly bacteria adherence to intestinal mucosa.

Maintain/support gastrointestinal system health

Maintain/support gastrointestinal system health when travelling

Maintain/support healthy gastrointestinal function

Maintain/support healthy gastrointestinal function when travelling

Maintain/support gastrointestinal mucosal membrane health

Aids/assists repair of gastrointestinal/gut wall lining

Maintain/support immune system health

Maintain/support healthy immune system function

Maintain/support healthy immune system function in healthy infants

Maintain/support healthy gastrointestinal immune function

Aid/assist/helps protein synthesis in the body

Maintain/support (state vitamin/mineral/nutrient) levels in the body

Public Summary

Page 1 of

Produced at 29.08.2019 at 05:01:20 AEST

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Maintain/support nervous system health

Maintain/support nervous system function

Maintain/support female reproductive system health

Maintain/support/regulate healthy menstrual cycle

Maintain/support reproductive system health

Maintain/support healthy reproductive hormones

Maintain/support sperm production

Maintain/support skin health

Maintain/support skin integrity/structure

Maintain/support wound healing in healthy individuals

Maintain/support skin repair/healing/regeneration in healthy individuals

Indication Requirements

If product is indicated for supplementation, Label statement: Vitamins and minerals can only be of assistance if dietary intake is inadequate OR Vitamin

and/or mineral supplements should not replace a

Label statement: If symptoms persist, talk to your health professional.

Product presentation must not imply or refer to serious immunological diseases.

Product presentation must not imply or refer to infertility.

Product presentation must not imply or refer to hormone imbalances.

Label statement: Vitamins and minerals can only be of assistance if dietary intake is inadequate OR Vitamin and/or mineral supplements should not

replace a balanced diet.

Product presentation must not imply or refer to mental illnesses, disorders or conditions.

Product presentation must not imply or refer to vision correction, faults or serious eye disease e.g. macular degeneration.

Standard Indications

No Standard Indications included on Record

Specific Indications

Warnings

WARNING: May be dangerous if taken in large amounts or for a long period. OR WARNING: Contains zinc which may be dangerous if taken in large

amounts or for a long period (or words to that effect).

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Capsule, hard

Route of Administration

Oral

Visual Identification

Active Ingredients

polaprezinc

39.5 mg

Saccharomyces cerevisiae (Boulardii)

5 billion CFU

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 29.08.2019 at 05:01:20 AEST

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Similar products

Search alerts related to this product

Share this information